The FDA approved a new safety warning for Depo-Provera alerting patients to a possible risk for a type of brain tumor called ...

As of 2025, lawsuits are now underway against Pfizer, the manufacturer of Depo-Provera, filed by women who were diagnosed with meningioma after using the birth control shot. These cases allege that ...

WESTWEGO, Louisiana — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For ...

A March 2024 study published by The BMJ revealed that women who were injected with Depo-Provera (medroxyprogesterone acetate) are more than five times more likely to be diagnosed with a type of brain ...

Recent studies how found evidence that Depo-Provera massively increases the risk of developing brain tumors even after women ...

Depot medroxyprogesterone acetate (DMPA) can prevent pregnancy for up to three months, and is available in a form that can be ...

Leading lawsuit funder prepared to financially assist victims while they seek justice for their injury claims, including vision loss and brain tumors. JERSEY CITY, N.J., June 12, 2025 /PRNewswire/ -- ...

The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...

Pfizer site manufacturing heparin active pharmaceutical ingredient. Pfizer is a pharmaceutical biotechnology corporation. U.S. government regulators have approved a new brain tumor warning for ...

THURSDAY, Dec. 18, 2025 (HealthDay News — The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot made by Pfizer, alerting patients ...